MedPath

BYNOCS DAT game treatment for Amblyopia treatment in adults.

Not Applicable
Recruiting
Conditions
Health Condition 1: H518- Other specified disorders of binocular movement
Registration Number
CTRI/2022/12/048361
Lead Sponsor
Kanohi Eye Private Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients meeting following inclusion criteria will be eligible for participation in the study:

Ability to give informed consent.

Subjects both male and female with age 18 years and above.

Patients with any type of non-strabismic, iso ametropic, anisometropic or meridonial amblyopia.

Without any systemic or ophthalmic comorbidities

Amblyopic patients with acuities between 20/40 (0.30 log MAR) to 20/200 (1.00 Log MAR)

Patients with and computer knowledge and ability to play games using computer

Exclusion Criteria

Patients meeting any of the following exclusion criteria will not be eligible for participation in the study

â?? Patients with Sensory deprivation or Strabismic amblyopia, or has eccentric fixation

â?? Patients who have taken treatment for non-strabismic amblyopia within 6 weeks of study recruitment

â?? Refractive error greater than 6.00D

â?? Patients undergone previous intraocular or refractive surgery

â?? Patients with any corneal irregularity

â?? Patients with opacification of ocular media including cataracts and active ocular disease

â?? Patients suffering from Glaucoma, nystagmus, uncontrolled diabetes, and uncontrolled high blood pressure in the opinion of a PI.

â?? Other ocular or systemic diseases that will affect visual acuity.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in best-corrected distance visual acuity in the amblyopic eye by 0.2 log MAR improvement compared to baseline after initiating game play.Timepoint: 6 weeks and 12 weeks
Secondary Outcome Measures
NameTimeMethod
â?? Change from baseline in stereopsis measured using by Titmus test. <br/ ><br>â??Change from baseline in interocular suppression by performing Worth 4 Dot Test. <br/ ><br>â?? Change from Baseline in contrast sensitivity at 12 weeks with using Pelli Robson chart <br/ ><br> <br/ ><br>â?? Change from baseline in degree of binocular vision at 12 weeks by performing Worth 4 Dot Test. <br/ ><br>Timepoint: â?¢12 weeks <br/ ><br>â?¢12 weeks <br/ ><br>â?¢12 weeks <br/ ><br>â?¢12 weeks <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath